Biogen Inc
BIIB
$235.35+1.08%
End of day · as of Oct 15, 2026, 5:17 PM ET
Mkt cap
$29.33B
EV/Sales
3.60
P/E ratio
N/A
FY2025 Revenue
$9.89B
EPS (9mo ended 2025-09-30)
$9.14
Gross Margin (FY2025)
75.69%
Profit Margin (FY2025)
13.07%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B.
Use this BIIB research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full BIIB income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Biogen Inc (BIIB) is a drug manufacturers - general company in the Healthcare sector.
Latest cached Biogen Inc (BIIB) revenue for Dec 31, 2025 was $9.89B. Net income was $1.29B. Statements: https://lician.com/financials/biib
Biogen Inc (BIIB) market capitalization is $29.33B on the latest cached snapshot.
Biogen Inc (BIIB) cached previous close $232.83; day range $235.33 – $236.10; volume 1,312,945. Session quote: https://lician.com/quote/biib
Biogen Inc (BIIB) latest cached earnings event is "BIIB earnings" on Jul 30, 2026. Earnings calendar: https://lician.com/earnings
The latest cached BIIB filing is 8-K · Jul 29, 2026. Filings: https://lician.com/sec/biib